---
title: "Terumo brings Medis QFR 3.0 to US market"
date: "2025-04-17T08:56:18.000Z"
publishedDate: "17 avril 2025"
summary: "Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), has announced that Medis QFR 3.0, a US Food and Drug Administration (FDA)-cleared software solution for coronary physiology assessment, is now available in the USA through its collaboration with Medis Medical Imaging. &#8220;Helping hospitals access proven, innovative tools like QFR 3.0 is an important [&#8230;] The post Terumo brings Medis QFR 3.0 to US market appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/terumo-brings-medis-qfr-3-0-to-us-market/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-04-17-terumo-brings-medis-qfr-30-to-us-market"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/02/Terumo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/terumo-brings-medis-qfr-3-0-to-us-market/"
---

![Terumo brings Medis QFR 3.0 to US market](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/02/Terumo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/terumo-brings-medis-qfr-3-0-to-us-market/*

## L’essentiel

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), has announced that Medis QFR 3.0, a US Food and Drug Administration (FDA)-cleared software solution for coronary physiology assessment, is now available in the USA through its collaboration with Medis Medical Imaging. &#8220;Helping hospitals access proven, innovative tools like QFR 3.0 is an important [&#8230;] The post Terumo brings Medis QFR 3.0 to US market appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/terumo-brings-medis-qfr-3-0-to-us-market/
